Deferasirox 73190-0052-30
- Manufacturer
- Avkare
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 14, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA210945
Need to source Deferasirox? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Deferasirox | 360 mg/1 |
Drug Class
Iron Chelator [EPC]Cytochrome P450 1A2 Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]
Selected Package
73190-0052-30Selected30 TABLET in 1 BOTTLE (73190-052-30)